Details for New Drug Application (NDA): 203289
✉ Email this page to a colleague
NDA 203289 describes CALCITRIOL, which is a drug marketed by Amneal Pharms, Bionpharma, Hikma, Strides Pharma, Sun Pharm, Teva, Am Regent, Fresenius Kabi Usa, Fresenius Medcl, Gland Pharma Ltd, Hospira, Long Grove Pharms, Rockwell Medcl, Sagent Pharms, Teva Parenteral, Anda Repository, and Rising, and is included in eighteen NDAs. It is available from twenty suppliers. Additional details are available on the CALCITRIOL profile page.
The generic ingredient in CALCITRIOL is calcitriol. There are ten drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the calcitriol profile page.
The generic ingredient in CALCITRIOL is calcitriol. There are ten drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the calcitriol profile page.
Summary for 203289
| Tradename: | CALCITRIOL |
| Applicant: | Amneal Pharms |
| Ingredient: | calcitriol |
| Patents: | 0 |
Suppliers and Packaging for NDA: 203289
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CALCITRIOL | calcitriol | CAPSULE;ORAL | 203289 | ANDA | Amneal Pharmaceuticals LLC | 65162-519 | 65162-519-03 | 30 CAPSULE in 1 BOTTLE (65162-519-03) |
| CALCITRIOL | calcitriol | CAPSULE;ORAL | 203289 | ANDA | Amneal Pharmaceuticals LLC | 65162-519 | 65162-519-10 | 100 CAPSULE in 1 BOTTLE (65162-519-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 0.5MCG | ||||
| Approval Date: | Jun 14, 2017 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 0.25MCG | ||||
| Approval Date: | Jun 14, 2017 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
